Fintech PR
Equity Indexed Life Insurance Market to Reach $14.90 billion, Globally, by 2032 at 14.6% CAGR: Allied Market Research
The equity indexed life insurance market is driven by the increasing demand for both wealth accumulation and downside protection.
PORTLAND, Ore., Oct. 13, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Equity indexed life insurance Market Whole Life Insurance, Universal life Insurance, Variable Universal Life Insurance, Indexed Universal Life Insurance and Others), Mode (Online, and Offline), and Distribution Channel (Insurance Companies, Agency and Brokers, and Banks) Global Opportunity Analysis and Industry Forecast, 2022–2032.”. According to the report, the global Equity indexed life insurance industry generated $ 3.9 billion in 2022 and is anticipated to generate $ 14.9 billion by 2032, witnessing a CAGR of 14.6% from 2023 to 2032.
In an era of market volatility and low interest rates, individuals are seeking investment options that provide potential for growth while ensuring a level of security. Equity indexed life insurance policies offer a unique combination of market-linked returns with a guaranteed minimum interest rate, making them an attractive choice for those looking to balance risk and potential rewards in their long-term financial planning.
(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution, Potential and COVID-19 Impact Analysis)
- 125 – Tables
- 67 – Charts
- 415 – Pages
Download Research Report Sample & TOC: https://www.alliedmarketresearch.com/request-sample/223491
Prime Determinants of Growth
The prime determinants of growth for the equity indexed life insurance market hinge on several crucial factors. Firstly, the prevailing economic environment plays a significant role. In periods of low interest rates and market volatility, individuals are drawn to investment options that offer both growth potential and downside protection, precisely the strengths of equity indexed life insurance. Additionally, demographic shifts and an aging population contribute to market expansion. As individuals seek to secure their financial future and pass on wealth to beneficiaries, these policies become an appealing instrument. Moreover, heightened awareness and education about the benefits of equity indexed life insurance, along with advancements in financial technology, have enhanced accessibility and understanding, driving further growth in this market.
Report Coverage & Details:
|
Report Coverage |
Details |
|
Forecast Period |
2023–2032 |
|
Base Year |
2022 |
|
Market Size in 2022 |
$ 3.9 billion |
|
Market Size in 2032 |
$ 14.9 billion |
|
CAGR |
14.6 % |
|
No. of Pages in Report |
415 |
|
Segments Covered |
Type, Mode, Distribution Channel, and Region. |
|
Drivers |
Investor interest and market performance Consumer awareness and education Technological advancements |
|
Opportunities |
Long-term investment perspective |
|
Restraints |
Complexity and lack of transparency Competing insurance products |
The whole life insurance segment to maintain its leadership status throughout the forecast period
Based on the type, the whole life insurance segment held the highest market share in 2022, accounting for nearly two-fifths of the global equity indexed life insurance market revenue and is estimated to maintain its leadership status throughout the forecast period, driven by people seeking long-term financial protection and a way to accumulate savings over time. The growth factors include a stable, guaranteed death benefit and tax advantages. However, the variable universal life insurance segment is projected to manifest the highest CAGR of 19.5% from 2023 to 2032, VUL policies provide flexibility for policyholders to invest their premiums in various investment options such as stocks, bonds, or mutual funds. This flexibility attracts individuals looking for potential higher returns on their investments while still securing life insurance coverage.
The online segment to maintain its leadership status throughout the forecast period
Based on the mode, the online segment held the highest market share in 2022, accounting for more than two-thirds of the global equity indexed life insurance market revenue, owing to the convenience of online applications and instant quotes simplifies the purchasing process, attracting a broader. However, the offline segment is projected to manifest the highest CAGR of 16.7% from 2022 to 2032, attributing to the expanding aging population seeking stable investments for retirement, and the desire for financial protection in uncertain times.
The agency and brokers segment to maintain its leadership status throughout the forecast period
Based on distribution channel, the agency and brokers segment held the highest market share in 2022, accounting for nearly half of the global equity indexed life insurance market revenue, this is attributed to the fact that agents and brokers provide ongoing support, ensuring policyholders understand their investments and helping them make informed decisions, thereby increasing customer retention and market stability. However, the banks segment is projected to manifest the highest CAGR of 16.9% from 2022 to 2032. Banks leverage their existing customer relationships to cross-sell EILI policies, capitalizing on the trust customers have in their financial institutions. This built-in trust factor can significantly boost the EILI market’s growth.
Get Customized Reports with your Requirements: https://www.alliedmarketresearch.com/request-for-customization/223491
North America to maintain its dominance by 2032
Based on region, North America held the highest market share in terms of revenue in 2022. Growing interest in insurance products that offer potential for higher returns compared to traditional whole-life or term-life policies is one of the major factor for the growth of the market in this region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 18.1% from 2023 to 2032 and is likely to dominate the market during the forecast period. As people’s incomes rise, they have more disposable income to invest in insurance products like EILI. In addition, EILI has gained popularity in Asia-Pacific due to its potential for both life insurance coverage and investment growth.
Leading Market Players: –
- American International Group, Inc.
- AXA
- John Hancock
- MetLife Services and Solutions, LLC.
- Mutual of Omaha Insurance Company
- Penn Mutual
- Progressive Casualty Insurance Company
- Protective Life Corporation
- Prudential Financial, Inc.
- Symetra Life Insurance Company
The report provides a detailed analysis of these key players in the global equity indexed life insurance market. These players have adopted different strategies such as expansion, merger, and product launches to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Inquiry before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/223491
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the equity indexed life insurance market forecast from 2022 to 2032 to identify the prevailing equity indexed life insurance market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the equity indexed life insurance market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global equity indexed life insurance market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the equity indexed life insurance market players.
- The equity indexed life insurance market report includes the analysis of the regional as well as global equity indexed life insurance market trends, key players, market segments, application areas, and market growth strategies.
Equity Indexed Life Insurance Market Key Segments:
By Type:
- Whole Life Insurance
- Universal Life Insurance
- Variable Universal Life Insurance
- Indexed Universal Life Insurance
- Others
By Mode:
- Online
- Offline
By Distribution Channel:
- Insurance Companies
- Agency and Brokers
- Banks
By Region:
- North America (U.S., Canada)
- Europe (UK, Germany, France, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific)
- LAMEA (Latin America, Middle East, Africa)
Procure Complete Report (415 Pages PDF with Insights, Charts, Tables, and Figures) @ https://bit.ly/48U5l3q
Trending Reports in BFSI Industry (Book Now with 10% Discount + COVID-19 Scenario):
Commercial Property Insurance Market by Coverage (Open Perils, Named Perils), by Distribution Channels (Agents and Brokers, Direct Response, Others), by Enterprise Size (Large Enterprises, Small and Medium-sized Enterprises), by Industry Vertical (Manufacturing, Construction, IT and Telecom, Healthcare, Energy and Utilities, Transportation and Logistics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032.
Dental Insurance Market by Coverage (Dental Preferred Provider Organizations (DPPO), Dental Health Maintenance Organizations (DHMO), Dental Indemnity Plans, and Others), Procedure Type (Major, Basic, and Preventive), Demographics (Senior Citizens, Adults, and Minors), and End User (Individuals and Corporates): Global Opportunity Analysis and Industry Forecast, 2020-2027.
Fire Insurance Market by Coverage (Standard Coverage and Optional Coverage), Enterprise Size (Large Enterprises and Small and Medium Enterprises) and Industry Vertical (Manufacturing, Healthcare, Energy & Utilities, Retail & Consumer Goods, IT & Telecom, Hospitality and Others): Global Opportunity Analysis and Industry Forecast, 2021-2028.
Insurance Advertising Market by Product Type (Life Insurance, Non-life Insurance), by Advertising Channels (Television, Email, Sales Calls, Others), by Application (Direct Marketing, Network Marketing, Mobile Marketing, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032.
Blockchain in Insurance Market by Component (Solution, Service), by Application (GRC Management, Claims Management, Identity Management and Fraud Detection, Payments, Others), by Enterprise Size (Large Enterprises, Small and Medium-sized Enterprises): Global Opportunity Analysis and Industry Forecast, 2021-2031.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
[email protected]
Allied Market Research Blog: https://blog.alliedmarketresearch.com
BFSI Blog
Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/equity-indexed-life-insurance-market-to-reach-14-90-billion-globally-by-2032-at-14-6-cagr-allied-market-research-301956213.html
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News7 days ago
Trina Storage Recognized as Tier 1 Energy Storage Manufacturer by BNEF for Second Consecutive Quarter
-
Latest News7 days ago
EQT to acquire WSO2, a leading global provider of digital transformation technologies
-
Latest News7 days agoGenome and Chilli Partners join forces to revolutionize iGaming affiliate payouts
-
Latest News7 days ago
Bank of Spain grants Amadeus’ Outpayce EMI licence
-
Latest News7 days ago
Newmark Reports First Quarter 2024 Financial Results
-
Latest News7 days ago
REALTY ONE GROUP CELEBRATES 19TH ANNIVERSARY WITH GLOBAL ‘ONE DAY’ OF VOLUNTEERING & GIVING BACK
-
Latest News7 days ago
BIZCLIK MEDIA LAUNCHES MAY EDITION OF FINTECH MAGAZINE
-
Latest News4 days ago
TerraPay Continues to Attract Top Industry Talent, Names Hassan Chatila as Vice President and Global Head of Network
